(no text — see the shared post below)

Glucosamine linked to lower mortality and CVD events in three cohort studies
The poster reviews observational studies: a 2012 US cohort (n = 77,510) with 33% lower mortality, UK Biobank (nearly 500,000) with 15% lower cardiovascular events, and a 2020 US cohort (~16,700) with 65% lower CV mortality. He proposes anti-inflammatory and anti-aging mechanisms, noting RCT proof is lacking.






